COSCIENS Biopharma Inc. (CSCIF)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $6.06
- As of
Kresmion compiles this page from CSCIF's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
COSCIENS Biopharma Inc. (CSCIF): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-07-06.
See the full CSCIF dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CSCIF on one page. Preview it with sample data, then open it live with a free account.
Preview the CSCIF dossierActive events for CSCIF
- mediumEarnings above estimates
Q1-2023: Beat consensus by 19.4% - EPS $-3.52 vs $-4.3656 estimate
- mediumEarnings above estimates
Q2-2023: Beat consensus by 41.4% - EPS $-2.08 vs $-3.5496 estimate
- mediumEarnings below estimates
Q3-2023: Missed consensus by 36.6% - EPS $-3.4 vs $-2.4888 estimate
- mediumEarnings below estimates
Q4-2023: Missed consensus by 17.2% - EPS $-4.64 vs $-3.9576 estimate
FREE, NO ACCOUNT
Every event on CSCIF, as it fires
New filings, 13F moves and cross asset events on CSCIF land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter.
Recent SEC filings, CSCIF
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 20-FSEC EDGAR ↗
Going concern statement
CSCIF's 20-F filed Mar 25, 2026 states:
Our history of losses and negative cash flows from operations and the need for substantial capital raise substantial doubt about our ability to continue as a going concern.
Read the 20-F on SEC EDGAR Every company with a going concern statement
More data on CSCIF
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in CSCIF on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on CSCIF in the last 180 days.
Upstream: SEC EDGAR filings for CSCIF
Kresmion, "COSCIENS Biopharma Inc. (CSCIF) institutional holdings and SEC filings", data as of 2026-07-06, https://kresmion.com/research/CSCIF. Upstream data: SEC EDGAR filings for CSCIF.
Link to this data (HTML):
<a href="https://kresmion.com/research/CSCIF">COSCIENS Biopharma Inc. (CSCIF) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow CSCIF on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to CSCIF for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.